Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

Ultragenyx Pharmaceutical Inc. RARE

Set alert

Price alert · RARE

All alert types
16.10 USD -0.68 -4.05%

At close · Oct 30

16.10 0.00 0.00%

After hours · Oct 30, 6:49 PM ET

Bid
16.08 × 2
Ask
16.10 × 2
15.92 Day range 16.93
12.88 52-week range 36.54
YTD
-30.00%
1 year
-54.22%
Open
16.64
Prev close
16.78
Mkt cap
1.59B
Vol
2.33M
Avg vol
4.20M
EPS
-5.82
P/E
0.00
Div yield
0.00%
More statistics
Low
15.92
High
16.93
Forward P/E
71.30
Beta
0.35
Short ratio
3.79
Inst. own
118.43%
Dividend
0.00
Ex-div date
Earnings
Nov 3, 2026
50-d avg
17.20
200-d avg
22.94
1y target
26.25

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for RARE has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-5.22 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-2 / 5 overall

  • DCF 5
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -3.9×
FY 2016: -11.3×FY 2017: -6.5×FY 2018: -11.0×FY 2019: -6.0×FY 2020: -45.1×FY 2021: -12.6×FY 2022: -4.6×FY 2023: -5.8×FY 2024: -6.7×FY 2025: -3.9×
FY 2016 5y median -5.8× FY 2025
P/S 3.4×
FY 2016: 20927×FY 2017: 754×FY 2018: 42.0×FY 2019: 23.3×FY 2020: 31.1×FY 2021: 16.2×FY 2022: 8.9×FY 2023: 8.1×FY 2024: 6.8×FY 2025: 3.4×
FY 2016 5y median 8.1× FY 2025
P/B -28.3×
FY 2016: 5.9×FY 2017: 5.1×FY 2018: 3.6×FY 2019: 3.7×FY 2020: 7.3×FY 2021: 6.2×FY 2022: 9.2×FY 2023: 12.8×FY 2024: 14.9×FY 2025: -28.3×
FY 2016 5y median 9.2× FY 2025
P/FCF -4.8×
FY 2016: -16.3×FY 2017: -7.7×FY 2018: -7.3×FY 2019: -6.5×FY 2020: -47.8×FY 2021: -13.8×FY 2022: -6.2×FY 2023: -6.7×FY 2024: -9.0×FY 2025: -4.8×
FY 2016 5y median -6.7× FY 2025
EV/EBITDA -6.6×
FY 2016: -10.7×FY 2017: -6.0×FY 2018: -11.5×FY 2019: -5.2×FY 2020: -55.5×FY 2021: -13.2×FY 2022: -4.9×FY 2023: -6.5×FY 2024: -7.8×FY 2025: -6.6×
FY 2016 5y median -6.6× FY 2025
EV/Sales 4.6×
FY 2016: 19716×FY 2017: 715×FY 2018: 39.8×FY 2019: 19.5×FY 2020: 28.6×FY 2021: 15.5×FY 2022: 8.6×FY 2023: 7.7×FY 2024: 6.6×FY 2025: 4.6×
FY 2016 5y median 7.7× FY 2025
FCF Yield -20.8%
FY 2016: -6.1%FY 2017: -13.0%FY 2018: -13.6%FY 2019: -15.3%FY 2020: -2.1%FY 2021: -7.2%FY 2022: -16.3%FY 2023: -14.8%FY 2024: -11.1%FY 2025: -20.8%
FY 2016 5y median -14.8% FY 2025

Profitability

Gross Margin 83.8%
FY 2016: -137647.4%FY 2017: 100.0%FY 2018: 97.8%FY 2019: 91.3%FY 2020: 97.7%FY 2021: 95.4%FY 2022: 92.2%FY 2023: 89.6%FY 2024: 86.3%FY 2025: 83.8%
FY 2016 5y median 89.6% FY 2025
Operating Margin -79.5%
FY 2016: -186471.4%FY 2017: -12593.5%FY 2018: -721.2%FY 2019: -409.0%FY 2020: -121.8%FY 2021: -108.6%FY 2022: -178.6%FY 2023: -131.1%FY 2024: -95.7%FY 2025: -79.5%
FY 2016 5y median -108.6% FY 2025
Net Margin -85.4%
FY 2016: -184867.7%FY 2017: -11567.3%FY 2018: -383.7%FY 2019: -388.3%FY 2020: -68.8%FY 2021: -129.2%FY 2022: -194.7%FY 2023: -139.7%FY 2024: -101.6%FY 2025: -85.4%
FY 2016 5y median -129.2% FY 2025
ROE 718.8%
FY 2016: -51.9%FY 2017: -78.8%FY 2018: -32.5%FY 2019: -61.6%FY 2020: -16.2%FY 2021: -49.2%FY 2022: -200.7%FY 2023: -220.3%FY 2024: -222.9%FY 2025: 718.8%
FY 2016 5y median -200.7% FY 2025
ROIC -43.5%
FY 2016: -51.6%FY 2017: -74.4%FY 2018: -57.6%FY 2019: -40.8%FY 2020: -20.9%FY 2021: -28.2%FY 2022: -50.1%FY 2023: -46.4%FY 2024: -45.8%FY 2025: -43.5%
FY 2016 5y median -45.8% FY 2025
ROA -37.5%
FY 2016: -45.5%FY 2017: -61.6%FY 2018: -27.5%FY 2019: -35.5%FY 2020: -10.6%FY 2021: -29.8%FY 2022: -45.8%FY 2023: -40.7%FY 2024: -37.9%FY 2025: -37.5%
FY 2016 5y median -37.9% FY 2025

Growth (YoY)

Revenue 20.1%
FY 2016: 0.0%FY 2017: 1863.9%FY 2018: 1871.5%FY 2019: 101.4%FY 2020: 161.3%FY 2021: 29.7%FY 2022: 3.4%FY 2023: 19.5%FY 2024: 29.0%FY 2025: 20.1%
FY 2016 FY 2025
Operating Income 0.2%
FY 2016: -67.9%FY 2017: -32.6%FY 2018: -12.9%FY 2019: -14.2%FY 2020: 22.2%FY 2021: -15.6%FY 2022: -70.0%FY 2023: 12.3%FY 2024: 5.8%FY 2025: 0.2%
FY 2016 FY 2025
EPS (diluted) 7.3%
FY 2016: -56.8%FY 2017: -14.7%FY 2018: 44.2%FY 2019: -79.3%FY 2020: 56.9%FY 2021: -118.2%FY 2022: -51.0%FY 2023: 18.5%FY 2024: 23.8%FY 2025: 7.3%
FY 2016 FY 2025
Free Cash Flow -11.9%
FY 2016: -54.3%FY 2017: -49.9%FY 2018: -14.8%FY 2019: -25.6%FY 2020: 52.4%FY 2021: -133.8%FY 2022: -27.9%FY 2023: 1.0%FY 2024: 19.2%FY 2025: -11.9%
FY 2016 FY 2025

Financial Health

Current Ratio 2.5×
FY 2016: 8.3×FY 2017: 3.4×FY 2018: 7.0×FY 2019: 8.2×FY 2020: 6.8×FY 2021: 4.7×FY 2022: 3.4×FY 2023: 2.6×FY 2024: 2.4×FY 2025: 2.5×
FY 2016 5y median 2.6× FY 2025
Quick Ratio 2.3×
FY 2016: 8.3×FY 2017: 3.4×FY 2018: 6.9×FY 2019: 8.1×FY 2020: 6.8×FY 2021: 4.6×FY 2022: 3.3×FY 2023: 2.5×FY 2024: 2.2×FY 2025: 2.3×
FY 2016 5y median 2.5× FY 2025
Debt / Equity -15.9×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.1×FY 2023: 0.2×FY 2024: 0.2×FY 2025: -15.9×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA -1.8×
FY 2016: 0.7×FY 2017: 0.3×FY 2018: 0.6×FY 2019: 1.0×FY 2020: 4.8×FY 2021: 0.6×FY 2022: 0.2×FY 2023: 0.3×FY 2024: 0.3×FY 2025: -1.8×
FY 2016 5y median 0.3× FY 2025
Interest Coverage -8.6×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: -374×FY 2020: -9.9×FY 2021: -13.0×FY 2022: -15.1×FY 2023: -8.6×FY 2024: -8.5×FY 2025: -8.6×
FY 2016 5y median -8.6× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31